Global Pharmaceutical CDMO Industry Research Report, Competitive Landscape, Market Size, Regional Status and Prospect
The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the Pharmaceutical CDMO market covering all its essential aspects.
For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.
In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.
Key players in the global Pharmaceutical CDMO market are covered in Chapter 9:
Quanticate Ltd
PRA Health Sciences Inc.
Pharmaceutical Product Development LLC
Sagimet Biosciences (3V Biosciences Inc.)
Syneos Health Inc.
Covance Inc.
PAREXEL International Corporation
IQVIA Holdings Inc.
In Chapter 5 and Chapter 7.3, based on types, the Pharmaceutical CDMO market from 2017 to 2027 is primarily split into:
Small Molecule CDMO
Peptide CDMO
Others
In Chapter 6 and Chapter 7.4, based on applications, the Pharmaceutical CDMO market from 2017 to 2027 covers:
Small & Mid-Size Pharma Companies
Generic Pharmaceutical Companies
Big Pharma Companies
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Pharmaceutical CDMO market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Pharmaceutical CDMO Industry.
2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.
3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.
Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.
4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.
Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.
Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.
Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.
Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.
Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.
Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.
Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.
Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.
Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.
Chapter 11 introduces the market research methods and data sources.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.
In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.
Key players in the global Pharmaceutical CDMO market are covered in Chapter 9:
Quanticate Ltd
PRA Health Sciences Inc.
Pharmaceutical Product Development LLC
Sagimet Biosciences (3V Biosciences Inc.)
Syneos Health Inc.
Covance Inc.
PAREXEL International Corporation
IQVIA Holdings Inc.
In Chapter 5 and Chapter 7.3, based on types, the Pharmaceutical CDMO market from 2017 to 2027 is primarily split into:
Small Molecule CDMO
Peptide CDMO
Others
In Chapter 6 and Chapter 7.4, based on applications, the Pharmaceutical CDMO market from 2017 to 2027 covers:
Small & Mid-Size Pharma Companies
Generic Pharmaceutical Companies
Big Pharma Companies
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Pharmaceutical CDMO market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Pharmaceutical CDMO Industry.
2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.
3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.
Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.
4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.
Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.
Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.
Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.
Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.
Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.
Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.
Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.
Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.
Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.
Chapter 11 introduces the market research methods and data sources.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
1 PHARMACEUTICAL CDMO MARKET OVERVIEW
1.1 Product Overview and Scope of Pharmaceutical CDMO Market
1.2 Pharmaceutical CDMO Market Segment by Type
1.2.1 Global Pharmaceutical CDMO Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Pharmaceutical CDMO Market Segment by Application
1.3.1 Pharmaceutical CDMO Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Pharmaceutical CDMO Market, Region Wise (2017-2027)
1.4.1 Global Pharmaceutical CDMO Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Pharmaceutical CDMO Market Status and Prospect (2017-2027)
1.4.3 Europe Pharmaceutical CDMO Market Status and Prospect (2017-2027)
1.4.4 China Pharmaceutical CDMO Market Status and Prospect (2017-2027)
1.4.5 Japan Pharmaceutical CDMO Market Status and Prospect (2017-2027)
1.4.6 India Pharmaceutical CDMO Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Pharmaceutical CDMO Market Status and Prospect (2017-2027)
1.4.8 Latin America Pharmaceutical CDMO Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Pharmaceutical CDMO Market Status and Prospect (2017-2027)
1.5 Global Market Size of Pharmaceutical CDMO (2017-2027)
1.5.1 Global Pharmaceutical CDMO Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Pharmaceutical CDMO Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Pharmaceutical CDMO Market
2 INDUSTRY OUTLOOK
2.1 Pharmaceutical CDMO Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Pharmaceutical CDMO Market Drivers Analysis
2.4 Pharmaceutical CDMO Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Pharmaceutical CDMO Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Pharmaceutical CDMO Industry Development
3 GLOBAL PHARMACEUTICAL CDMO MARKET LANDSCAPE BY PLAYER
3.1 Global Pharmaceutical CDMO Sales Volume and Share by Player (2017-2022)
3.2 Global Pharmaceutical CDMO Revenue and Market Share by Player (2017-2022)
3.3 Global Pharmaceutical CDMO Average Price by Player (2017-2022)
3.4 Global Pharmaceutical CDMO Gross Margin by Player (2017-2022)
3.5 Pharmaceutical CDMO Market Competitive Situation and Trends
3.5.1 Pharmaceutical CDMO Market Concentration Rate
3.5.2 Pharmaceutical CDMO Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL PHARMACEUTICAL CDMO SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Pharmaceutical CDMO Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Pharmaceutical CDMO Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Pharmaceutical CDMO Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Pharmaceutical CDMO Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Pharmaceutical CDMO Market Under COVID-19
4.5 Europe Pharmaceutical CDMO Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Pharmaceutical CDMO Market Under COVID-19
4.6 China Pharmaceutical CDMO Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Pharmaceutical CDMO Market Under COVID-19
4.7 Japan Pharmaceutical CDMO Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Pharmaceutical CDMO Market Under COVID-19
4.8 India Pharmaceutical CDMO Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Pharmaceutical CDMO Market Under COVID-19
4.9 Southeast Asia Pharmaceutical CDMO Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Pharmaceutical CDMO Market Under COVID-19
4.10 Latin America Pharmaceutical CDMO Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Pharmaceutical CDMO Market Under COVID-19
4.11 Middle East and Africa Pharmaceutical CDMO Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Pharmaceutical CDMO Market Under COVID-19
5 GLOBAL PHARMACEUTICAL CDMO SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Pharmaceutical CDMO Sales Volume and Market Share by Type (2017-2022)
5.2 Global Pharmaceutical CDMO Revenue and Market Share by Type (2017-2022)
5.3 Global Pharmaceutical CDMO Price by Type (2017-2022)
5.4 Global Pharmaceutical CDMO Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Pharmaceutical CDMO Sales Volume, Revenue and Growth Rate of Small Molecule CDMO (2017-2022)
5.4.2 Global Pharmaceutical CDMO Sales Volume, Revenue and Growth Rate of Peptide CDMO (2017-2022)
5.4.3 Global Pharmaceutical CDMO Sales Volume, Revenue and Growth Rate of Others (2017-2022)
6 GLOBAL PHARMACEUTICAL CDMO MARKET ANALYSIS BY APPLICATION
6.1 Global Pharmaceutical CDMO Consumption and Market Share by Application (2017-2022)
6.2 Global Pharmaceutical CDMO Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Pharmaceutical CDMO Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Pharmaceutical CDMO Consumption and Growth Rate of Small & Mid-Size Pharma Companies (2017-2022)
6.3.2 Global Pharmaceutical CDMO Consumption and Growth Rate of Generic Pharmaceutical Companies (2017-2022)
6.3.3 Global Pharmaceutical CDMO Consumption and Growth Rate of Big Pharma Companies (2017-2022)
6.3.4 Global Pharmaceutical CDMO Consumption and Growth Rate of Others (2017-2022)
7 GLOBAL PHARMACEUTICAL CDMO MARKET FORECAST (2022-2027)
7.1 Global Pharmaceutical CDMO Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Pharmaceutical CDMO Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Pharmaceutical CDMO Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Pharmaceutical CDMO Price and Trend Forecast (2022-2027)
7.2 Global Pharmaceutical CDMO Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Pharmaceutical CDMO Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Pharmaceutical CDMO Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Pharmaceutical CDMO Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Pharmaceutical CDMO Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Pharmaceutical CDMO Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Pharmaceutical CDMO Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Pharmaceutical CDMO Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Pharmaceutical CDMO Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Pharmaceutical CDMO Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Pharmaceutical CDMO Revenue and Growth Rate of Small Molecule CDMO (2022-2027)
7.3.2 Global Pharmaceutical CDMO Revenue and Growth Rate of Peptide CDMO (2022-2027)
7.3.3 Global Pharmaceutical CDMO Revenue and Growth Rate of Others (2022-2027)
7.4 Global Pharmaceutical CDMO Consumption Forecast by Application (2022-2027)
7.4.1 Global Pharmaceutical CDMO Consumption Value and Growth Rate of Small & Mid-Size Pharma Companies(2022-2027)
7.4.2 Global Pharmaceutical CDMO Consumption Value and Growth Rate of Generic Pharmaceutical Companies(2022-2027)
7.4.3 Global Pharmaceutical CDMO Consumption Value and Growth Rate of Big Pharma Companies(2022-2027)
7.4.4 Global Pharmaceutical CDMO Consumption Value and Growth Rate of Others(2022-2027)
7.5 Pharmaceutical CDMO Market Forecast Under COVID-19
8 PHARMACEUTICAL CDMO MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Pharmaceutical CDMO Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Pharmaceutical CDMO Analysis
8.6 Major Downstream Buyers of Pharmaceutical CDMO Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Pharmaceutical CDMO Industry
9 PLAYERS PROFILES
9.1 Quanticate Ltd
9.1.1 Quanticate Ltd Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Pharmaceutical CDMO Product Profiles, Application and Specification
9.1.3 Quanticate Ltd Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 PRA Health Sciences Inc.
9.2.1 PRA Health Sciences Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Pharmaceutical CDMO Product Profiles, Application and Specification
9.2.3 PRA Health Sciences Inc. Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Pharmaceutical Product Development LLC
9.3.1 Pharmaceutical Product Development LLC Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Pharmaceutical CDMO Product Profiles, Application and Specification
9.3.3 Pharmaceutical Product Development LLC Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Sagimet Biosciences (3V Biosciences Inc.)
9.4.1 Sagimet Biosciences (3V Biosciences Inc.) Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Pharmaceutical CDMO Product Profiles, Application and Specification
9.4.3 Sagimet Biosciences (3V Biosciences Inc.) Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 Syneos Health Inc.
9.5.1 Syneos Health Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Pharmaceutical CDMO Product Profiles, Application and Specification
9.5.3 Syneos Health Inc. Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Covance Inc.
9.6.1 Covance Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Pharmaceutical CDMO Product Profiles, Application and Specification
9.6.3 Covance Inc. Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 PAREXEL International Corporation
9.7.1 PAREXEL International Corporation Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Pharmaceutical CDMO Product Profiles, Application and Specification
9.7.3 PAREXEL International Corporation Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 IQVIA Holdings Inc.
9.8.1 IQVIA Holdings Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Pharmaceutical CDMO Product Profiles, Application and Specification
9.8.3 IQVIA Holdings Inc. Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
1.1 Product Overview and Scope of Pharmaceutical CDMO Market
1.2 Pharmaceutical CDMO Market Segment by Type
1.2.1 Global Pharmaceutical CDMO Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Pharmaceutical CDMO Market Segment by Application
1.3.1 Pharmaceutical CDMO Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Pharmaceutical CDMO Market, Region Wise (2017-2027)
1.4.1 Global Pharmaceutical CDMO Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Pharmaceutical CDMO Market Status and Prospect (2017-2027)
1.4.3 Europe Pharmaceutical CDMO Market Status and Prospect (2017-2027)
1.4.4 China Pharmaceutical CDMO Market Status and Prospect (2017-2027)
1.4.5 Japan Pharmaceutical CDMO Market Status and Prospect (2017-2027)
1.4.6 India Pharmaceutical CDMO Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Pharmaceutical CDMO Market Status and Prospect (2017-2027)
1.4.8 Latin America Pharmaceutical CDMO Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Pharmaceutical CDMO Market Status and Prospect (2017-2027)
1.5 Global Market Size of Pharmaceutical CDMO (2017-2027)
1.5.1 Global Pharmaceutical CDMO Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Pharmaceutical CDMO Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Pharmaceutical CDMO Market
2 INDUSTRY OUTLOOK
2.1 Pharmaceutical CDMO Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Pharmaceutical CDMO Market Drivers Analysis
2.4 Pharmaceutical CDMO Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Pharmaceutical CDMO Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Pharmaceutical CDMO Industry Development
3 GLOBAL PHARMACEUTICAL CDMO MARKET LANDSCAPE BY PLAYER
3.1 Global Pharmaceutical CDMO Sales Volume and Share by Player (2017-2022)
3.2 Global Pharmaceutical CDMO Revenue and Market Share by Player (2017-2022)
3.3 Global Pharmaceutical CDMO Average Price by Player (2017-2022)
3.4 Global Pharmaceutical CDMO Gross Margin by Player (2017-2022)
3.5 Pharmaceutical CDMO Market Competitive Situation and Trends
3.5.1 Pharmaceutical CDMO Market Concentration Rate
3.5.2 Pharmaceutical CDMO Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL PHARMACEUTICAL CDMO SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Pharmaceutical CDMO Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Pharmaceutical CDMO Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Pharmaceutical CDMO Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Pharmaceutical CDMO Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Pharmaceutical CDMO Market Under COVID-19
4.5 Europe Pharmaceutical CDMO Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Pharmaceutical CDMO Market Under COVID-19
4.6 China Pharmaceutical CDMO Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Pharmaceutical CDMO Market Under COVID-19
4.7 Japan Pharmaceutical CDMO Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Pharmaceutical CDMO Market Under COVID-19
4.8 India Pharmaceutical CDMO Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Pharmaceutical CDMO Market Under COVID-19
4.9 Southeast Asia Pharmaceutical CDMO Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Pharmaceutical CDMO Market Under COVID-19
4.10 Latin America Pharmaceutical CDMO Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Pharmaceutical CDMO Market Under COVID-19
4.11 Middle East and Africa Pharmaceutical CDMO Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Pharmaceutical CDMO Market Under COVID-19
5 GLOBAL PHARMACEUTICAL CDMO SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Pharmaceutical CDMO Sales Volume and Market Share by Type (2017-2022)
5.2 Global Pharmaceutical CDMO Revenue and Market Share by Type (2017-2022)
5.3 Global Pharmaceutical CDMO Price by Type (2017-2022)
5.4 Global Pharmaceutical CDMO Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Pharmaceutical CDMO Sales Volume, Revenue and Growth Rate of Small Molecule CDMO (2017-2022)
5.4.2 Global Pharmaceutical CDMO Sales Volume, Revenue and Growth Rate of Peptide CDMO (2017-2022)
5.4.3 Global Pharmaceutical CDMO Sales Volume, Revenue and Growth Rate of Others (2017-2022)
6 GLOBAL PHARMACEUTICAL CDMO MARKET ANALYSIS BY APPLICATION
6.1 Global Pharmaceutical CDMO Consumption and Market Share by Application (2017-2022)
6.2 Global Pharmaceutical CDMO Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Pharmaceutical CDMO Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Pharmaceutical CDMO Consumption and Growth Rate of Small & Mid-Size Pharma Companies (2017-2022)
6.3.2 Global Pharmaceutical CDMO Consumption and Growth Rate of Generic Pharmaceutical Companies (2017-2022)
6.3.3 Global Pharmaceutical CDMO Consumption and Growth Rate of Big Pharma Companies (2017-2022)
6.3.4 Global Pharmaceutical CDMO Consumption and Growth Rate of Others (2017-2022)
7 GLOBAL PHARMACEUTICAL CDMO MARKET FORECAST (2022-2027)
7.1 Global Pharmaceutical CDMO Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Pharmaceutical CDMO Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Pharmaceutical CDMO Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Pharmaceutical CDMO Price and Trend Forecast (2022-2027)
7.2 Global Pharmaceutical CDMO Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Pharmaceutical CDMO Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Pharmaceutical CDMO Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Pharmaceutical CDMO Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Pharmaceutical CDMO Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Pharmaceutical CDMO Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Pharmaceutical CDMO Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Pharmaceutical CDMO Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Pharmaceutical CDMO Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Pharmaceutical CDMO Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Pharmaceutical CDMO Revenue and Growth Rate of Small Molecule CDMO (2022-2027)
7.3.2 Global Pharmaceutical CDMO Revenue and Growth Rate of Peptide CDMO (2022-2027)
7.3.3 Global Pharmaceutical CDMO Revenue and Growth Rate of Others (2022-2027)
7.4 Global Pharmaceutical CDMO Consumption Forecast by Application (2022-2027)
7.4.1 Global Pharmaceutical CDMO Consumption Value and Growth Rate of Small & Mid-Size Pharma Companies(2022-2027)
7.4.2 Global Pharmaceutical CDMO Consumption Value and Growth Rate of Generic Pharmaceutical Companies(2022-2027)
7.4.3 Global Pharmaceutical CDMO Consumption Value and Growth Rate of Big Pharma Companies(2022-2027)
7.4.4 Global Pharmaceutical CDMO Consumption Value and Growth Rate of Others(2022-2027)
7.5 Pharmaceutical CDMO Market Forecast Under COVID-19
8 PHARMACEUTICAL CDMO MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Pharmaceutical CDMO Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Pharmaceutical CDMO Analysis
8.6 Major Downstream Buyers of Pharmaceutical CDMO Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Pharmaceutical CDMO Industry
9 PLAYERS PROFILES
9.1 Quanticate Ltd
9.1.1 Quanticate Ltd Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Pharmaceutical CDMO Product Profiles, Application and Specification
9.1.3 Quanticate Ltd Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 PRA Health Sciences Inc.
9.2.1 PRA Health Sciences Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Pharmaceutical CDMO Product Profiles, Application and Specification
9.2.3 PRA Health Sciences Inc. Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Pharmaceutical Product Development LLC
9.3.1 Pharmaceutical Product Development LLC Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Pharmaceutical CDMO Product Profiles, Application and Specification
9.3.3 Pharmaceutical Product Development LLC Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Sagimet Biosciences (3V Biosciences Inc.)
9.4.1 Sagimet Biosciences (3V Biosciences Inc.) Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Pharmaceutical CDMO Product Profiles, Application and Specification
9.4.3 Sagimet Biosciences (3V Biosciences Inc.) Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 Syneos Health Inc.
9.5.1 Syneos Health Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Pharmaceutical CDMO Product Profiles, Application and Specification
9.5.3 Syneos Health Inc. Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Covance Inc.
9.6.1 Covance Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Pharmaceutical CDMO Product Profiles, Application and Specification
9.6.3 Covance Inc. Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 PAREXEL International Corporation
9.7.1 PAREXEL International Corporation Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Pharmaceutical CDMO Product Profiles, Application and Specification
9.7.3 PAREXEL International Corporation Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 IQVIA Holdings Inc.
9.8.1 IQVIA Holdings Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Pharmaceutical CDMO Product Profiles, Application and Specification
9.8.3 IQVIA Holdings Inc. Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
LIST OF TABLES AND FIGURES
Figure Pharmaceutical CDMO Product Picture
Table Global Pharmaceutical CDMO Market Sales Volume and CAGR (%) Comparison by Type
Table Pharmaceutical CDMO Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Pharmaceutical CDMO Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Pharmaceutical CDMO Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Pharmaceutical CDMO Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Pharmaceutical CDMO Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Pharmaceutical CDMO Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Pharmaceutical CDMO Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Pharmaceutical CDMO Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Pharmaceutical CDMO Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Pharmaceutical CDMO Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Pharmaceutical CDMO Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Pharmaceutical CDMO Industry Development
Table Global Pharmaceutical CDMO Sales Volume by Player (2017-2022)
Table Global Pharmaceutical CDMO Sales Volume Share by Player (2017-2022)
Figure Global Pharmaceutical CDMO Sales Volume Share by Player in 2021
Table Pharmaceutical CDMO Revenue (Million USD) by Player (2017-2022)
Table Pharmaceutical CDMO Revenue Market Share by Player (2017-2022)
Table Pharmaceutical CDMO Price by Player (2017-2022)
Table Pharmaceutical CDMO Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Pharmaceutical CDMO Sales Volume, Region Wise (2017-2022)
Table Global Pharmaceutical CDMO Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Pharmaceutical CDMO Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Pharmaceutical CDMO Sales Volume Market Share, Region Wise in 2021
Table Global Pharmaceutical CDMO Revenue (Million USD), Region Wise (2017-2022)
Table Global Pharmaceutical CDMO Revenue Market Share, Region Wise (2017-2022)
Figure Global Pharmaceutical CDMO Revenue Market Share, Region Wise (2017-2022)
Figure Global Pharmaceutical CDMO Revenue Market Share, Region Wise in 2021
Table Global Pharmaceutical CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Pharmaceutical CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Pharmaceutical CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Pharmaceutical CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Pharmaceutical CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Pharmaceutical CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Pharmaceutical CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Pharmaceutical CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Pharmaceutical CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Pharmaceutical CDMO Sales Volume by Type (2017-2022)
Table Global Pharmaceutical CDMO Sales Volume Market Share by Type (2017-2022)
Figure Global Pharmaceutical CDMO Sales Volume Market Share by Type in 2021
Table Global Pharmaceutical CDMO Revenue (Million USD) by Type (2017-2022)
Table Global Pharmaceutical CDMO Revenue Market Share by Type (2017-2022)
Figure Global Pharmaceutical CDMO Revenue Market Share by Type in 2021
Table Pharmaceutical CDMO Price by Type (2017-2022)
Figure Global Pharmaceutical CDMO Sales Volume and Growth Rate of Small Molecule CDMO (2017-2022)
Figure Global Pharmaceutical CDMO Revenue (Million USD) and Growth Rate of Small Molecule CDMO (2017-2022)
Figure Global Pharmaceutical CDMO Sales Volume and Growth Rate of Peptide CDMO (2017-2022)
Figure Global Pharmaceutical CDMO Revenue (Million USD) and Growth Rate of Peptide CDMO (2017-2022)
Figure Global Pharmaceutical CDMO Sales Volume and Growth Rate of Others (2017-2022)
Figure Global Pharmaceutical CDMO Revenue (Million USD) and Growth Rate of Others (2017-2022)
Table Global Pharmaceutical CDMO Consumption by Application (2017-2022)
Table Global Pharmaceutical CDMO Consumption Market Share by Application (2017-2022)
Table Global Pharmaceutical CDMO Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Pharmaceutical CDMO Consumption Revenue Market Share by Application (2017-2022)
Table Global Pharmaceutical CDMO Consumption and Growth Rate of Small & Mid-Size Pharma Companies (2017-2022)
Table Global Pharmaceutical CDMO Consumption and Growth Rate of Generic Pharmaceutical Companies (2017-2022)
Table Global Pharmaceutical CDMO Consumption and Growth Rate of Big Pharma Companies (2017-2022)
Table Global Pharmaceutical CDMO Consumption and Growth Rate of Others (2017-2022)
Figure Global Pharmaceutical CDMO Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Pharmaceutical CDMO Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Pharmaceutical CDMO Price and Trend Forecast (2022-2027)
Figure USA Pharmaceutical CDMO Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Pharmaceutical CDMO Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Pharmaceutical CDMO Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Pharmaceutical CDMO Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Pharmaceutical CDMO Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Pharmaceutical CDMO Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Pharmaceutical CDMO Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Pharmaceutical CDMO Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Pharmaceutical CDMO Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Pharmaceutical CDMO Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Pharmaceutical CDMO Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Pharmaceutical CDMO Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Pharmaceutical CDMO Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Pharmaceutical CDMO Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Pharmaceutical CDMO Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Pharmaceutical CDMO Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Pharmaceutical CDMO Market Sales Volume Forecast, by Type
Table Global Pharmaceutical CDMO Sales Volume Market Share Forecast, by Type
Table Global Pharmaceutical CDMO Market Revenue (Million USD) Forecast, by Type
Table Global Pharmaceutical CDMO Revenue Market Share Forecast, by Type
Table Global Pharmaceutical CDMO Price Forecast, by Type
Figure Global Pharmaceutical CDMO Revenue (Million USD) and Growth Rate of Small Molecule CDMO (2022-2027)
Figure Global Pharmaceutical CDMO Revenue (Million USD) and Growth Rate of Small Molecule CDMO (2022-2027)
Figure Global Pharmaceutical CDMO Revenue (Million USD) and Growth Rate of Peptide CDMO (2022-2027)
Figure Global Pharmaceutical CDMO Revenue (Million USD) and Growth Rate of Peptide CDMO (2022-2027)
Figure Global Pharmaceutical CDMO Revenue (Million USD) and Growth Rate of Others (2022-2027)
Figure Global Pharmaceutical CDMO Revenue (Million USD) and Growth Rate of Others (2022-2027)
Table Global Pharmaceutical CDMO Market Consumption Forecast, by Application
Table Global Pharmaceutical CDMO Consumption Market Share Forecast, by Application
Table Global Pharmaceutical CDMO Market Revenue (Million USD) Forecast, by Application
Table Global Pharmaceutical CDMO Revenue Market Share Forecast, by Application
Figure Global Pharmaceutical CDMO Consumption Value (Million USD) and Growth Rate of Small & Mid-Size Pharma Companies (2022-2027)
Figure Global Pharmaceutical CDMO Consumption Value (Million USD) and Growth Rate of Generic Pharmaceutical Companies (2022-2027)
Figure Global Pharmaceutical CDMO Consumption Value (Million USD) and Growth Rate of Big Pharma Companies (2022-2027)
Figure Global Pharmaceutical CDMO Consumption Value (Million USD) and Growth Rate of Others (2022-2027)
Figure Pharmaceutical CDMO Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Quanticate Ltd Profile
Table Quanticate Ltd Pharmaceutical CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Quanticate Ltd Pharmaceutical CDMO Sales Volume and Growth Rate
Figure Quanticate Ltd Revenue (Million USD) Market Share 2017-2022
Table PRA Health Sciences Inc. Profile
Table PRA Health Sciences Inc. Pharmaceutical CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure PRA Health Sciences Inc. Pharmaceutical CDMO Sales Volume and Growth Rate
Figure PRA Health Sciences Inc. Revenue (Million USD) Market Share 2017-2022
Table Pharmaceutical Product Development LLC Profile
Table Pharmaceutical Product Development LLC Pharmaceutical CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Pharmaceutical Product Development LLC Pharmaceutical CDMO Sales Volume and Growth Rate
Figure Pharmaceutical Product Development LLC Revenue (Million USD) Market Share 2017-2022
Table Sagimet Biosciences (3V Biosciences Inc.) Profile
Table Sagimet Biosciences (3V Biosciences Inc.) Pharmaceutical CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Sagimet Biosciences (3V Biosciences Inc.) Pharmaceutical CDMO Sales Volume and Growth Rate
Figure Sagimet Biosciences (3V Biosciences Inc.) Revenue (Million USD) Market Share 2017-2022
Table Syneos Health Inc. Profile
Table Syneos Health Inc. Pharmaceutical CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Syneos Health Inc. Pharmaceutical CDMO Sales Volume and Growth Rate
Figure Syneos Health Inc. Revenue (Million USD) Market Share 2017-2022
Table Covance Inc. Profile
Table Covance Inc. Pharmaceutical CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Covance Inc. Pharmaceutical CDMO Sales Volume and Growth Rate
Figure Covance Inc. Revenue (Million USD) Market Share 2017-2022
Table PAREXEL International Corporation Profile
Table PAREXEL International Corporation Pharmaceutical CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure PAREXEL International Corporation Pharmaceutical CDMO Sales Volume and Growth Rate
Figure PAREXEL International Corporation Revenue (Million USD) Market Share 2017-2022
Table IQVIA Holdings Inc. Profile
Table IQVIA Holdings Inc. Pharmaceutical CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure IQVIA Holdings Inc. Pharmaceutical CDMO Sales Volume and Growth Rate
Figure IQVIA Holdings Inc. Revenue (Million USD) Market Share 2017-2022
Figure Pharmaceutical CDMO Product Picture
Table Global Pharmaceutical CDMO Market Sales Volume and CAGR (%) Comparison by Type
Table Pharmaceutical CDMO Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Pharmaceutical CDMO Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Pharmaceutical CDMO Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Pharmaceutical CDMO Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Pharmaceutical CDMO Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Pharmaceutical CDMO Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Pharmaceutical CDMO Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Pharmaceutical CDMO Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Pharmaceutical CDMO Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Pharmaceutical CDMO Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Pharmaceutical CDMO Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Pharmaceutical CDMO Industry Development
Table Global Pharmaceutical CDMO Sales Volume by Player (2017-2022)
Table Global Pharmaceutical CDMO Sales Volume Share by Player (2017-2022)
Figure Global Pharmaceutical CDMO Sales Volume Share by Player in 2021
Table Pharmaceutical CDMO Revenue (Million USD) by Player (2017-2022)
Table Pharmaceutical CDMO Revenue Market Share by Player (2017-2022)
Table Pharmaceutical CDMO Price by Player (2017-2022)
Table Pharmaceutical CDMO Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Pharmaceutical CDMO Sales Volume, Region Wise (2017-2022)
Table Global Pharmaceutical CDMO Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Pharmaceutical CDMO Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Pharmaceutical CDMO Sales Volume Market Share, Region Wise in 2021
Table Global Pharmaceutical CDMO Revenue (Million USD), Region Wise (2017-2022)
Table Global Pharmaceutical CDMO Revenue Market Share, Region Wise (2017-2022)
Figure Global Pharmaceutical CDMO Revenue Market Share, Region Wise (2017-2022)
Figure Global Pharmaceutical CDMO Revenue Market Share, Region Wise in 2021
Table Global Pharmaceutical CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Pharmaceutical CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Pharmaceutical CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Pharmaceutical CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Pharmaceutical CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Pharmaceutical CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Pharmaceutical CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Pharmaceutical CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Pharmaceutical CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Pharmaceutical CDMO Sales Volume by Type (2017-2022)
Table Global Pharmaceutical CDMO Sales Volume Market Share by Type (2017-2022)
Figure Global Pharmaceutical CDMO Sales Volume Market Share by Type in 2021
Table Global Pharmaceutical CDMO Revenue (Million USD) by Type (2017-2022)
Table Global Pharmaceutical CDMO Revenue Market Share by Type (2017-2022)
Figure Global Pharmaceutical CDMO Revenue Market Share by Type in 2021
Table Pharmaceutical CDMO Price by Type (2017-2022)
Figure Global Pharmaceutical CDMO Sales Volume and Growth Rate of Small Molecule CDMO (2017-2022)
Figure Global Pharmaceutical CDMO Revenue (Million USD) and Growth Rate of Small Molecule CDMO (2017-2022)
Figure Global Pharmaceutical CDMO Sales Volume and Growth Rate of Peptide CDMO (2017-2022)
Figure Global Pharmaceutical CDMO Revenue (Million USD) and Growth Rate of Peptide CDMO (2017-2022)
Figure Global Pharmaceutical CDMO Sales Volume and Growth Rate of Others (2017-2022)
Figure Global Pharmaceutical CDMO Revenue (Million USD) and Growth Rate of Others (2017-2022)
Table Global Pharmaceutical CDMO Consumption by Application (2017-2022)
Table Global Pharmaceutical CDMO Consumption Market Share by Application (2017-2022)
Table Global Pharmaceutical CDMO Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Pharmaceutical CDMO Consumption Revenue Market Share by Application (2017-2022)
Table Global Pharmaceutical CDMO Consumption and Growth Rate of Small & Mid-Size Pharma Companies (2017-2022)
Table Global Pharmaceutical CDMO Consumption and Growth Rate of Generic Pharmaceutical Companies (2017-2022)
Table Global Pharmaceutical CDMO Consumption and Growth Rate of Big Pharma Companies (2017-2022)
Table Global Pharmaceutical CDMO Consumption and Growth Rate of Others (2017-2022)
Figure Global Pharmaceutical CDMO Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Pharmaceutical CDMO Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Pharmaceutical CDMO Price and Trend Forecast (2022-2027)
Figure USA Pharmaceutical CDMO Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Pharmaceutical CDMO Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Pharmaceutical CDMO Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Pharmaceutical CDMO Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Pharmaceutical CDMO Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Pharmaceutical CDMO Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Pharmaceutical CDMO Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Pharmaceutical CDMO Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Pharmaceutical CDMO Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Pharmaceutical CDMO Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Pharmaceutical CDMO Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Pharmaceutical CDMO Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Pharmaceutical CDMO Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Pharmaceutical CDMO Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Pharmaceutical CDMO Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Pharmaceutical CDMO Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Pharmaceutical CDMO Market Sales Volume Forecast, by Type
Table Global Pharmaceutical CDMO Sales Volume Market Share Forecast, by Type
Table Global Pharmaceutical CDMO Market Revenue (Million USD) Forecast, by Type
Table Global Pharmaceutical CDMO Revenue Market Share Forecast, by Type
Table Global Pharmaceutical CDMO Price Forecast, by Type
Figure Global Pharmaceutical CDMO Revenue (Million USD) and Growth Rate of Small Molecule CDMO (2022-2027)
Figure Global Pharmaceutical CDMO Revenue (Million USD) and Growth Rate of Small Molecule CDMO (2022-2027)
Figure Global Pharmaceutical CDMO Revenue (Million USD) and Growth Rate of Peptide CDMO (2022-2027)
Figure Global Pharmaceutical CDMO Revenue (Million USD) and Growth Rate of Peptide CDMO (2022-2027)
Figure Global Pharmaceutical CDMO Revenue (Million USD) and Growth Rate of Others (2022-2027)
Figure Global Pharmaceutical CDMO Revenue (Million USD) and Growth Rate of Others (2022-2027)
Table Global Pharmaceutical CDMO Market Consumption Forecast, by Application
Table Global Pharmaceutical CDMO Consumption Market Share Forecast, by Application
Table Global Pharmaceutical CDMO Market Revenue (Million USD) Forecast, by Application
Table Global Pharmaceutical CDMO Revenue Market Share Forecast, by Application
Figure Global Pharmaceutical CDMO Consumption Value (Million USD) and Growth Rate of Small & Mid-Size Pharma Companies (2022-2027)
Figure Global Pharmaceutical CDMO Consumption Value (Million USD) and Growth Rate of Generic Pharmaceutical Companies (2022-2027)
Figure Global Pharmaceutical CDMO Consumption Value (Million USD) and Growth Rate of Big Pharma Companies (2022-2027)
Figure Global Pharmaceutical CDMO Consumption Value (Million USD) and Growth Rate of Others (2022-2027)
Figure Pharmaceutical CDMO Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Quanticate Ltd Profile
Table Quanticate Ltd Pharmaceutical CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Quanticate Ltd Pharmaceutical CDMO Sales Volume and Growth Rate
Figure Quanticate Ltd Revenue (Million USD) Market Share 2017-2022
Table PRA Health Sciences Inc. Profile
Table PRA Health Sciences Inc. Pharmaceutical CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure PRA Health Sciences Inc. Pharmaceutical CDMO Sales Volume and Growth Rate
Figure PRA Health Sciences Inc. Revenue (Million USD) Market Share 2017-2022
Table Pharmaceutical Product Development LLC Profile
Table Pharmaceutical Product Development LLC Pharmaceutical CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Pharmaceutical Product Development LLC Pharmaceutical CDMO Sales Volume and Growth Rate
Figure Pharmaceutical Product Development LLC Revenue (Million USD) Market Share 2017-2022
Table Sagimet Biosciences (3V Biosciences Inc.) Profile
Table Sagimet Biosciences (3V Biosciences Inc.) Pharmaceutical CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Sagimet Biosciences (3V Biosciences Inc.) Pharmaceutical CDMO Sales Volume and Growth Rate
Figure Sagimet Biosciences (3V Biosciences Inc.) Revenue (Million USD) Market Share 2017-2022
Table Syneos Health Inc. Profile
Table Syneos Health Inc. Pharmaceutical CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Syneos Health Inc. Pharmaceutical CDMO Sales Volume and Growth Rate
Figure Syneos Health Inc. Revenue (Million USD) Market Share 2017-2022
Table Covance Inc. Profile
Table Covance Inc. Pharmaceutical CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Covance Inc. Pharmaceutical CDMO Sales Volume and Growth Rate
Figure Covance Inc. Revenue (Million USD) Market Share 2017-2022
Table PAREXEL International Corporation Profile
Table PAREXEL International Corporation Pharmaceutical CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure PAREXEL International Corporation Pharmaceutical CDMO Sales Volume and Growth Rate
Figure PAREXEL International Corporation Revenue (Million USD) Market Share 2017-2022
Table IQVIA Holdings Inc. Profile
Table IQVIA Holdings Inc. Pharmaceutical CDMO Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure IQVIA Holdings Inc. Pharmaceutical CDMO Sales Volume and Growth Rate
Figure IQVIA Holdings Inc. Revenue (Million USD) Market Share 2017-2022
